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Background: Avian Metapneumovirus (aMPV) infections are a huge economical issue for the poultry industry
worldwide. Although maternal antibodies do not protect turkey poults against turkey rhinotracheitis (TRT), almost
no studies have been conducted so far regarding the impact of these antibodies on vaccine induced immunity
development against aMPV infection. We conducted four experiments on commercial turkeys aimed at comparing
local humoral and cell mediated immune response of maternally delivered anti-aMPV antibody positive (MDA+;
Experiment I and II) and negative (MDA-; Experiment III and IV) turkeys following vaccination with an attenuated live
aMPV subtype A vaccine at the day of hatch (Experiment I and III) or at two weeks of age (Experiment II and IV).
Results: Regardless of the birds’ age, vaccination of MDA- turkeys resulted in strong stimulation of CD8+ T lymphocytes
in the Harderian gland and tracheal mucosa, whereas vaccination of MDA+ birds stimulated mainly CD4+ T cells in
those structures. An increase in the level of anti-aMPV IgY antibodies was noted in the serum (but not in tracheal
washings) as early as 7 days after vaccination, but only in birds possessing low levels (MDA+ birds vaccinated at 2 weeks
of age) or no maternal anti-aMPV antibodies at the time of vaccination. In MDA+ turkeys vaccinated at hatch, the
decrease in serum levels of maternal anti-aMPV antibodies proceeded faster (in comparison to control group), which,
together with faster viral clearance, indicates that maternal antibodies can inhibit vaccine virus replication and influence
the development of vaccine-induced immunity.
Conclusion: This study provides the first documented evidence that the frequency of TRT outbreaks in the field
and/or failure of TRT vaccination could be correlated with differences in the immunological status and/or age
of vaccinated turkeys.
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Maternally derived antibodiesBackground
The avian metapneumovirus (aMPV), a member of the
family Paramyxoviridae, genus Metapneumovirus [1], is
a strongly infectious RNA virus that causes turkey rhino-
tracheitis (TRT) in flocks of turkeys and the swollen
head syndrome (SHS) in chickens. aMPV infections
cause massive financial losses in the poultry industry
worldwide. aMPV was first identified in South Africa in* Correspondence: marcin.smialek@uwm.edu.pl
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unless otherwise stated.1978 [2], and since then, it has spread to numerous
countries, excluding Australia and Canada. aMPV has
been classified into 4 subtypes (A–D) based on its nu-
cleotide sequence and antigen structure [3-5].
In most immunoprophylaxis programs, one-day-old
turkey poults are administered live attenuated vaccines
against TRT by coarse spray to provide the earliest pos-
sible protection of the upper respiratory tract against
aMPV infections [6]. Despite the above, TRT outbreaks
in the field are noted very frequently [7-9].l. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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ation or aMPV infection [7,10-13], but antibodies do not
play a key role in protection against TRT and should not
be considered as indicators of immunity against aMPV
infections [7,9,11,12,14-16]. It has been shown, however,
that high antibody titers suppress aMPV replication in
the upper respiratory tract, thus alleviating the clinical
course of TRT [6,11,12,14]. In one-day-old turkey
poults, most of which originate from parent flocks vac-
cinated against TRT, the possible influence of maternal
antibodies on the development of vaccine-induced im-
munity against aMPV is questionable.
Cell-mediated immunity (CMI) is increasingly often
considered as the decisive factor in protection against
TRT. Unfortunately, little is known about local CMI
mechanisms in turkeys’ upper respiratory tract during
infections and after vaccination against TRT. These
mechanisms seem to play a particularly important role
because aMPV infects the host through mucosal sites in
the upper respiratory tract. Liman and Rautenschlein [7]
demonstrated a significant increase in the percentage of
CD4+ T lymphocytes with concurrent upregulation of
IL-6 and/or IFN-γ in the Harderian gland (HG) after
vaccination or infection with aMPV/A or B. Conversely,
Cha [17] reported an increase in the percentage of CD8+
T cells, but not in CD4+ T cells, in the upper respiratory
tract after aMPV/C inoculation. The cited results indi-
cate that CMI actively participates in protection against
aMPV infections and that local CMI mechanisms may
be related to age and the aMPV subtype.
In view of the diverse immunopathogenesis of TRT,
the aim of this study was to describe selected parameters
of local CMI and humoral immunity in the upper re-
spiratory tract of turkeys immunized against TRT with
live attenuated aMPV/A vaccines. The specific goal of the
study was to characterize the development of vaccine-
induced immunity in variously-aged birds and in turkeys
with, or without maternal anti – aMPV antibodies on the
day of vaccination.
Methods
The experimental procedures and animal handling pro-
cedures were conducted with the approval of the Local
Ethic Committee for Animal Experiments in Olsztyn,
Poland (resolution No. 37/2011).
Turkeys and vaccination
The experiments were carried out on 568 commercial
Hybrid Converter turkeys of both sexes. The birds were
not vaccinated at hatchery, and the absence of aMPV
genetic material in samples collected at hatch was con-
firmed by nested RT-PCR. The MDA+ group comprised
284 turkeys that were positive for maternally derived
antibodies and were obtained from a parent flockvaccinated against TRT (3 times with live aMPV/A vac-
cine and twice with inactivated vaccine). MDA+ birds
were provided by the Grelavi S.A. hatchery (a Hendrix
Genetics Company) in Kętrzyn, Poland. The MDA-
group consisted of 284 turkeys that were negative for
maternally derived antibodies and originated from a par-
ent flock not vaccinated against TRT (reproductive flock
from Canada). MDA- birds were provided by the Gerczak
Nord-Pol Hatchery in Laseczno, Poland.
Turkeys were housed in isolated units maintained at a
biosafety PCL 3 facility. Water and feed were given to
birds ad libitum. Birds were vaccinated with aMPV/A
strain BUT1 #8544 of lyophilized attenuated commercial
vaccine. Each bird was inoculated with 104 of tissue cul-
ture infectious doses (TCID50) per bird oculonasally.
Unvaccinated birds received sterile vaccine diluent.
Experimental design
Experiment I
Experiment I was carried out on 160 one-day-old MDA+
turkeys. The birds were randomly divided into vaccinated
(MDA+0/V) and unvaccinated (MDA+0/NV) groups.
Before vaccination, samples were collected from 24 ran-
domly selected turkeys for further analysis. The day of
vaccination (hatch day) was termed zero day of life (DOL),
and the results for samples collected on this day were
marked as zero day post-vaccination (DPV).
Birds of both groups were raised to 14 DOL, and fur-
ther samples were collected on 3, 7 and 14 DPV (from
20–24 birds in each group in each sampling).
In each sampling, choanal swabs (e-Swab, Copan Diag-
nostics, Canada) were collected from 5 birds for RT-PCR
analysis (swabs were stored at −76°C until further analysis)
and blood samples were collected from 15 birds. The birds
were euthanized, and HG and trachea (TC, cut from the
larynx to the cranial aperture of body cavity) were col-
lected. HG and TC were pooled from 4–6 birds per sam-
ple (the number of birds per sample were equal in each
sampling), which produced 4 samples of each organ for
flow cytometry analysis. Tracheal washings were collected
from 10 birds in each group by passing 1 ml of phosphate-
buffered saline (PBS, pH 7.2, Sigma Aldrich, Germany)
through the lumen of the trachea with a 2 ml syringe. The
trachea was massaged gently to intensify the washing ef-
fect. Following centrifugation, the supernatant and serum
samples were stored at −20°C for further use.
Experiment II
The experimental design was identical to that of Experi-
ment I. The experiment was carried out on 124 MDA+
turkeys raised until 14 dol. On 14 DOL, samples were
collected from 20 birds, and the remaining turkeys were di-
vided randomly into vaccinated (MDA+14/V) and unvac-
cinated (MDA+14/NV) groups. Similarly to Experiment I,
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vaccination (14 DOL) represent 0 DPV, and further samples
were collected on 3 (17 DOL), 7 (21 DOL) and 14 (28
DOL) DPV (from 16–20 birds in each group in each
sampling).
Experiment III
Experiment III was carried out on 160 one-day-old
MDA- turkeys. The experimental design and schedule,
the day of vaccination and the sample collection proto-
col were identical to those described in Experiment I.
Turkeys were divided into two groups of vaccinated
(MDA-0/V) and unvaccinated (MDA-0/NV) birds.
Experiment IV
Experiment IV was carried out on 124 fourteen-day-old
MDA- turkeys. The experimental design and schedule,
the day of vaccination and the sample collection proto-
col were identical to those described in Experiment II.
Turkeys were divided into two groups of vaccinated
(MDA-14/V) and unvaccinated (MDA-14/NV) birds.
Isolation and determination of mononuclear cell counts
HG were homogenized in a manual Dounce tissue
grinder in 3 ml of complete cell culture medium (RPMI
– 1640, 10% Fetal Bovine Serum (FBS), 1% MEM Non-
essential Amino Acids solution, 1% Penicillin – Strepto-
mycin, 1% HEPES, 1% Sodium pyruvate, Sigma Aldrich,
Germany) and filtered (70 μm mesh). After centrifuga-
tion in culture medium at 450 g for 10 min at 20°C, the
supernatant was discarded and cell pellets were resus-
pended in 3 ml of 40% Percoll density gradient and gently
layered on 3 ml of 60% Percoll. Percoll concentrations
were obtained by combining 100% Percoll solution
(Percoll with 10% Hank’s balanced salt solution, Sigma
Aldrich, Germany) with the appropriate amount of culture
medium. Mononuclear cells were collected from the inter-
phase after density centrifugation (20 min, 1900 g, 20°C)
and washed twice in PBS with 5% FBS.
TC were cut into 2–3 mm pieces and placed in 100 ml
an Erlenmeyer flask with 25 ml of DL-Dithiothreitol so-
lution (RPMI – 1640, 5% FBS, 1% HEPES, 2 mM DL-
Dithiothreitol, Sigma Aldrich, Germany) and incubated
at room temperature for 5 min to remove epithelial cells
with intraepithelial lymphocytes. TC were filtered
(70 μm mesh), and flasks were rinsed with RPMI – 1640
before collagenase treatment. TC were placed in 25 ml of
Collagenase type IV solution (RPMI – 1640, 1% HEPES,
1% Penicillin – Streptomycin, 200 Collagen Digestion
Units/ml, Sigma Aldrich, Germany) and incubated at 38°C
for 35 min to isolate lamina propria lymphocytes. TC were
filtered (70 μm mesh) after incubation. Filtrates from both
incubations were washed three times in culture medium.
Final pellets of intraepithelial lymphocytes were mergedwith lamina propria lymphocytes from the same sample,
they were washed and resuspended in 3 ml of 40% Percoll.
The isolation procedure was identical to that involving
HG. The obtained HG and TC mononuclear cells were re-
suspended in 1 ml of PBS, and the absolute lymphocyte
counts (ALC)/ml were calculated for each sample with the
Vi-cell XR (Beckman Coulter, USA) cell counter and cell
viability analyzer.
Flow cytometry and dual platform analysis
2.5 × 105 (or 1.25 × 105, depending on the ALC) of
viable mononuclear cells from HG or TC were stained
with monoclonal Mouse anti-Chicken CD4 - FITC
(clone 2–35) and CD8 - PE (clone 11–39) for T lympho-
cytes, or polyclonal Goat anti-Chicken IgM - FITC for B
cells (AbD Serotec, UK), incubated for 30 min on ice
and washed twice in PBS. The cells were analyzed with
the FACSCanto II (BD, USA) flow cytometer.
Data acquisition was performed in FACSDiva Software
6.1.3. (BD, USA). Cells were analyzed and immunophe-
notyped in the FloJo 7.5.5 (Tree Star, USA). Relative cell
counts (RCC) of T and B lymphocytes in HG and TC
were established in the above environment.
Absolute cell counts (ACC) of T and B cells were cal-
culated by dual platform analysis with the use of the fol-
lowing formula: ACC = (ALC * RCC)/100%. Data were
expressed as the mean ACC of CD4+ and CD8+ T lym-
phocytes or the mean x-fold change in ACC of IgM+ B
lymphocytes in vaccinated groups relative to control
groups.
Enzyme-linked immunosorbent assay (ELISA)
Sera and tracheal washings were tested for specific IgY
anti-aMPV antibodies with the APV Ab ELISA kit
(IDEXX Laboratories, USA). Sera of MDA- birds were
diluted 100-fold rather than 500-fold (manufacturer’s
recommendations) to enhance detection of low antibody
levels. 100-fold dilution, as a comparative to 500-fold,
was also used in analyses of MDA+14/V and NV serum.
Tracheal washings were incubated undiluted. Successive
steps of the procedure were performed according to the
manufacturer’s recommendations. ELISA was carried
out with the use of the Eppendorf epMotion 5075 LH
automated pipetting station (Eppendorf, Germany),
BioTek ELx405 automatic plate washer (BioTek, USA)
and BioTek ELx800 plate reader. The sample to posi-
tive (S/P)-ratio was calculated based on the ODs and
used to express the mean (S/P)-ratio +/− SD per group
and per DPV.
Nested RT-PCR
Nested RT-PCR was performed in accordance with the
protocol described in a previous study [18] with minor
modifications. RNA was extracted from choanal swabs
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to the manufacturer’s recommendations. The concentra-
tions and purity of extracted RNA were evaluated with
the NanoDrop 2000 spectrophotometer (ThermoScienti-
fic, USA). Samples ranging from 1.8 to 2.0 of the OD
260/280 ratio were used for further analysis. RT was
performed with the EnhancedAvian HS RT-PCR Kit
(Sigma-Aldrich, USA) according to the manufacturer’s
recommendations. PCR was performed with the use of
the HotStarTaq Plus Master Mix (Qiagen, Germany) and
the vapo.protect (Eppendorf, Germany) thermocycler.
The first PCR was carried out with 10 μl of HotStarTaq
Plus DNA, 0.1 μl of 100 μM primers G1+A and G6,
6.8 μl of RNase-free water and 3 μl of cDNA. Nested
PCR was performed with 10 μl of HotStarTaq Plus
DNA, 0.1 μl of 100 μM primers G8+A and G5, 2 μl of
CoralLoad PCR, 5.8 μl RNase-free water and 2 μl of the
amplicon from the first PCR. Primer sequences and
product sizes for every PCR are summarized in Table 1.
Both PCRs had the following thermal profile: 95°C for
5 min, 30 cycles of 94°C for 1 min, 54°C for 45 s, 72°C
for 45 s, and final elongation at 72°C for 10 min.
Nested PCR amplicons were analyzed in 2% agarose
gel with 0.5 μl/ml of ethidium bromide dye (Sigma-
Aldrich, USA). Electrophoresis results were visualized
with GelDoc XR+ (Bio-Rad, USA).Statistical analysis
The flow cytometry results were processed by Student’s
t-test for independent samples in Graphpad Prism 6
software (San Diego, USA) and results of serological
examination by non-parametric Mann–Whitney U-test
in Statistica PL V10. Differences were considered statisti-
cally significant at p ≤ 0.05 and highly significant at p ≤ 0.01.Results
Absolute lymphocyte count
No statistical differences in absolute lymphocyte counts
in HG and TC were observed between vaccinated and
unvaccinated birds in all experiments, excluding ALC in
TC in the MDA-14/V group. In this group, ALC in TC
on 14 DPV increased significantly in comparison with
control group (data not shown).Table 1 Sequences of the oligonucleotide primers used in
nested RT-PCR analysis and expected PCR product size
Primer Sequence Product size
G1+A 5′-GGGACAAGTATCTCTATG-3′ 444 bp
G6 5′-CTGACAAATTGGTCCTGATT-3′
G8+A 5′-CACTCACTGTTAGCGTCATA-3′ 268 bp
G5 5′-CAAAGArCCAATAAGCCCA -3′Flow cytometry analysis of T cells
In Experiment I, a highly significant and significant in-
crease in CD4+ T ACC was noted in the MDA+0/V
group on day 7 and 14 PV in HG and TC, respectively,
in comparison with virus-free birds (Figure 1A). In Ex-
periment II, CD4+ T ACC did not increase significantly
in vaccinated birds, but a brief increase of this parameter
was reported in HG on 7 DPV in the MDA+14/V group.
A significant decrease in CD4+ T ACC was observed in
the MDA+14/V group on 7 DPV in TC in comparison
with control (Figure 1B). The noted decrease was short-
lived and no significant differences in the value of ana-
lyzed parameter were reported between groups in Ex-
periment II on day 14 PV.
In Experiment III, significant increase in CD4+ T ACC
was noted on 14 DPV in HG in the MDA-0/V group,
whereas a significant decrease in this parameter was ob-
served in TC on 7 DPV in comparison with unvaccin-
ated birds (Figure 1C). In Experiment IV, a statistical
increase in CD4+ T ACC on day 7 PV and a highly signifi-
cant increase on day 14 PV were reported in HG of MDA-
14/V birds, whereas a significant decrease in CD4+ T ACC
in TC was observed on day 3 PV in comparison with un-
vaccinated turkeys (Figure 1D).
In Experiments I and II, no significant differences in
T CD8+ ACC were observed in neither HG nor TC
(Figures 2A and B). The number of these cells in-
creased briefly in vaccinated birds (in particular in
HG), but the observed changes were not statistically
significant.
In Experiment III, a highly significant increase in
CD8+ T ACC was reported in HG of MDA-0/V birds on
days 7 and 14 PV, and a highly significant decrease in
the analyzed parameter was observed in TC on 7 DPV
in comparison with unvaccinated birds (Figure 2C). The
recorded decrease in CD8+ T cell count was short-lived,
and on 14 DPV, a highly significant increase in this par-
ameter was reported in TC of vaccinated turkeys in
comparison with virus-free birds.
The most prominent infiltration of CD8+ T cells in-
duced by the vaccine virus was observed in Experiment
IV. In the MDA-14/V group, a highly significant increase
in CD8+ T ACC was noted in TC on days 7 and 14 PV
and in HG on 7 DPV in comparison with control. T
CD8+ cell counts in HG decreased significantly on 14
DPV (Figure 2D).
In Experiments III and IV, significant differences were
also observed in double-positive CD4+CD8+ T ACC
(data not shown). In Experiment III, a significant de-
crease in the absolute counts of double-positive T cells
was reported in the MDA-0/V group in TC on day 7 PV.
In Experiment IV, a highly significant increase in
double-positive T ACC was noted in both HG and TC
on 14 DPV. No statistical differences in CD4+CD8+ T
Figure 1 Summary of CD4+ ACC in HG and TC (n = 4) at different days post aMPV/A vaccination. Results for vaccinated (aMPV vacc.) and
not vaccinated (Not vacc.) groups in different experiments (A) Experiment I; groups MDA+0/V and MDA+0/NV; (B) Experiment II; groups MDA+14/V
and MDA+14/NV; (C) Experiment III; groups MDA-0/V and MDA-0/NV (D) Experiment IV; groups MDA-14/V and MDA-14/NV. Results for every
experiment are presented as mean CD4+ ACC ± SD. */**Significant differences at different DPV (T-test, *as p < 0,05, **as p < 0,01).
Figure 2 Summary of CD8+ ACC in HG and TC (n = 4) at different days post aMPV/A vaccination. Results for vaccinated (aMPV vacc.) and
not vaccinated (Not vacc.) groups in different experiments (A) Experiment I; groups MDA+0/V and MDA+0/NV; (B) Experiment II; groups MDA+14/V
and MDA+14/NV; (C) Experiment III; groups MDA-0/V and MDA-0/NV (D) Experiment IV; groups MDA-14/V and MDA-14/NV. Results for every
experiment are presented as mean CD8+ ACC ± SD. */**Significant differences at different DPV (T-test, *as p < 0,05, **as p < 0,01).
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and unvaccinated birds (data not shown).
Flow cytometry analysis of B cells
In Experiment I, a significant decrease in B IgM+ ACC
in TC was observed in MDA+0/V on 7 DPV in compari-
son with the unvaccinated group (Table 2). The above
decrease was transient, and no differences in B IgM+
ACC were observed on day 14 PV.
In Experiment II, B IgM+ ACC increased significantly
in HG of MDA+14/V birds on 7 DPV (Table 2).
In Experiments III and IV, vaccination against TRT in-
duced a highly significant increase in B IgM+ cell counts
in TC on 14 DPV (Table 2). In Experiment IV, the vac-
cine virus also caused a significant decrease in IgM+ B
cell count in HG of MDA-14/V birds on 14 DPV in
comparison with control.
Serology
No statistical differences in the level of specific anti –
aMPV antibodies in tracheal washes were observed be-
tween vaccinated and not vaccinated birds in any of the
experiments (Table 3). In all MDA+ groups on the day
of vaccination, in tracheal washes turkeys had detectable
maternally derived antibodies (Table 3), and their level
decreased with age in large part proportionally to their
level in the serum. Only in MDA-14/V group the level
of these antibodies increased in tracheal washes on day
14 PV, but this increase was not statistically significant
(Table 3).
In Experiment I, high level of anti-aMPV antibodies
were reported in the serum and tracheal washes on the
day of vaccination. In the MDA+0/V group, mean (S/P)-
ratios in the serum and tracheal washes decreased fasterTable 2 Mean x-fold change of IgM+ B ACC at days post
aMPV vaccinationa in HG and TC
Mean x-fold changeb
Experiment Group 0 3 7 14
I MDA+0/V HG 1 0,72 1,33 0,88
TC 1 0,83 0,75* 0,88
II MDA+14/V HG 1 1,23 1,49* 0,76
TC 1 1,28 1,32 1,08
III MDA-0/V HG 1 1,24 0,85 0,89
TC 1 1,31 0,91 1,66**
IV MDA-14/V HG 1 1,18 0,99 0,74*
TC 1 0,78 1,17 3,31**
aIn all experiments vaccinated birds were inoculated oculonassaly with 104
TCID50 of live attenuated aMPV/A vaccine.
bx-fold change =mean IgM+ B ACC of vaccinated group divided by mean IgM
+B ACC of not vaccinated group.
*/**Significant difference in mean IgM+ B ACC of vaccinated birds in
comparison to the not vaccinated group (T-test, *as p < 0,05 and **as p < 0,01).than in unvaccinated birds. In most of cases, the ob-
served decrease was not statistically significant, except
on day 3 PV when mean serum antibody level were sig-
nificantly lower in vaccinated turkeys than in unvaccin-
ated birds (Table 4).
In Experiment II, MDA levels were detectable on vac-
cination day with the mean (S/P)-ratio (at 500-fold dilu-
tion) of 0.41 (data not shown), which is twice the
recommended (S/P)-ratio (0.2) cut-off value. In the
MDA+14/V group, MDA levels increased significantly
on 14 DPV in comparison with unvaccinated birds, but
differences were noted only when serum were diluted
100-fold (Table 4), and not 500-fold (data not shown).
In Experiment III and IV, anti-aMPV antibodies were
not detected in the serum (at 100-fold dilution) or in tra-
cheal washes on the day of vaccination (Tables 3 and 4).
Serum level of anti-aMPV IgY antibodies in MDA-0/V in-
creased gradually after vaccination and peaked signifi-
cantly on 14 DPV (Table 4). Similar results were observed
in Experiment IV, where serum antibody levels in MDA-
14/V turkeys began to increase significantly (at 100-fold
serum dilution) on 7 DPV, and increased further on 14
DPV (Table 4).Molecular biology
The effectiveness of aMPV-A vaccine virus detection
varied considerably between experiments. Between day 3
and 7 PV in Experiments I and III, aMPV RNA was de-
tected by nested RT-PCR in 100% (5 out of 5) of choanal
swabs in both MDA+0/V and MDA-0/V groups. On 14
DPV, aMPV RNA was detected in 40% (2/5) and 100%
(5/5) of samples from groups MDA+0/V and MDA-0/V,
respectively (Table 5).
In Experiment II, aMPV RNA was barely detectable in
the MDA+14/V group. In this group, genetic material of
the vaccine virus was identified only on day 3 PV in 40%
(2/5) of choanal swabs. aMPV/A RNA was undetectable
on days 7 and 14 PV (Table 5).
In Experiment IV, no viral RNA was detected at any
stage of the experiment in choanal swabs of MDA-14/V
birds (Table 5). The viral genome was not identified in
unvaccinated birds in any experiments (data not shown).Discussion
Different TRT vaccination schedules in parent flocks of
turkeys are likely to cause highly variable transfer of spe-
cific anti-aMPV maternal antibodies to hatching poults.
Although these antibodies do not protect turkey poults
against TRT, their impact on the development of
vaccine-induced immunity against aMPV infections has
been investigated by very few studies. The present situ-
ation is problematic because most breeder turkey flocks
are kept in areas with endemic prevalence of aMPV [19].
Table 3 Tracheal washings anti – aMPV IgY antibody level after aMPV vaccinationa of turkeys
Mean (S/P)-ratio ± S.D.b at days post aMPV/A vaccination
Experiment Group 0 3 7 14
I MDA+0/V 1.152 ± 0.995 0.446 ± 0.476 0.117 ± 0.136 0.097 ± 0.102
MDA+0/NV 1.152 ± 0.995 0.598 ± 0.695 0.123 ± 0.204 0.128 ± 0.097
III MDA-0/V 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.005 ± 0.011
MDA-0/NV 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00
II MDA+14/V 0.128 ± 0.097 0.025 ± 0.036 0.022 ± 0.033 0.023 ± 0.025
MDA+14/NV 0.128 ± 0.097 0.025 ± 0.039 0.031 ± 0.039 0.025 ± 0.042
IV MDA-14/V 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.029 ± 0.058
MDA-14/NV 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00
aIn all experiments vaccinated birds were inoculated oculonassaly with 104 TCID50 of live attenuated aMPV/A vaccine.
b10 samples of undiluted tracheal washings per group were analyzed.
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the development of post-vaccination immunity between
MDA+ and MDA- turkeys immunized with an attenu-
ated aMPV strain (3B (Att.)) on 1 or 7 DOL. However,
the attenuated aMPV strain used by the cited authors
was characterized by a relatively high virulence index
indicated by post-vaccination clinical scoring system.
Contemporary TRT vaccines are less pathogenic, and
they do not cause such acute side effects [20,21]. Re-
evaluating research aiming to compare the development
of vaccine-induced immunity to aMPV infections in
MDA+ and MDA- birds has not been undertaken to date.
Liman and Rautenschlein [7] demonstrated that the per-
centage of CD4+ T cells subpopulation (but not CD8+ T
cells) increased briefly in HG of turkeys 7–14 DPV after
vaccination with aMPV/B or after infection with aMPV/A
or B, which corroborates our results for MDA+ vaccinated
birds. The cited authors suggested that the short-lived
protection against TRT offered by vaccination and the fre-
quency of TRT outbreaks could be explained by the tran-
sient character of the observed stimulation. Liman and
Rautenschlein [7] analyzed turkeys from a breeder flockTable 4 Serum anti – aMPV IgY antibody level after aMPV va
Mean S/P-ratio ± S
Experiment Group 0
I MDA+0/V (1:500)c 2.19 ± 1.87
MDA+0/NV (1:500) 2.19 ± 1.87
III MDA-0/V (1:100) 0.001 ± 0.00
MDA-0/NV (1:100) 0.001 ± 0.00
II MDA+14/V (1:100) 0.598 ± 0.492
MDA+14/NV (1:100) 0.598 ± 0.492
IV MDA-14/V (1:100) 0.00 ± 0.00
MDA-14/NV (1:100) 0.00 ± 0.00
aIn all experiments vaccinated birds were inoculated oculonassaly with 104 TCID50 o
b15 samples of serum were analyzed per group.
cSample dilution for ELISA procedure.
*/**Significant difference in mean (S/P)-ratio of vaccinated birds in comparison to thimmunized against TRT, and vaccinated the birds at the
age of 33 days when specific anti-aMPV IgY antibodies
could still be detected in their serum. Their findings cor-
roborate our observations and indicate that the presence
of maternal antibodies somehow protects the upper re-
spiratory tract of turkeys against infiltration by CD8+ T
cells regardless of the birds’ age. In this context, the
presence of specific antibodies could contribute to the
induction of aMPV/A immunophagocytosis through
opsonization of the vaccine virus. The above observation
is additionally validated by faster viral clearance in the
upper respiratory tract and a significant decrease in MDA
levels in MDA+0/V birds after vaccination.
Cha [17] demonstrated that inoculation of two-week
old MDA- turkeys with aMPV/C increased the percent-
age of CD8+ T cells in nasal turbinate mucosa, without
inducing any changes in the percentage of CD4+ T cells.
Additionally, an increase in absolute counts of CD4+
and CD8+ T cells was reported in HG in MDA- chickens
inoculated with aMPV/A or B [9], which is consistent
with our results in MDA- vaccinated groups. The ob-
served increase in absolute counts of both T cellccinationa of turkeys
.D.b at days post aMPV/A vaccination
3 7 14
0.9 ± 0.51* 0.57 ± 0.5 0.23 ± 0.16
1.9 ± 1.36 0.6 ± 0.62 0.41 ± 0.36
0.006 ± 0.01 0.015 ± 0.017 0.179 ± 0.164**
0.005 ± 0.005 0.005 ± 0.008 0.00 ± 0.00
0.42 ± 0.361 0.21 ± 0.200 0.307 ± 0.217*
0.423 ± 0.345 0.228 ± 0.242 0.140 ± 0.116
0.014 ± 0.038 0.034 ± 0.055* 0.123 ± 0.194*
0.00 ± 0.00 0.00 ± 0.00 0.00 ± 0.00
f live attenuated aMPV/A vaccine.
e not vaccinated group (U-test, *as p < 0,05 and **as p < 0,01).
Table 5 Detection of aMPV genome in choanal swabs of aMPV vaccinated turkeys by nested RT-PCR
Number of aMPV/A positive birds/totala at days post vaccination
Group Experiment 0 3 7 14
MDA+0/V I 0/5 5/5 5/5 2/5
MDA-0/V III 0/5 5/5 5/5 5/5
MDA+14/V II 0/5 2/5 0/5 0/5
MDA-14/V IV 0/5 0/5 0/5 0/5
aIn all experiments vaccinated birds were inoculated oculonassaly with 104 TCID50 of live attenuated aMPV/A vaccine.
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could indicate that CD4+ T cells alone are unable to
control the vaccine virus replication. Greater stimulation
of vaccine-induced humoral immunity in MDA- vacci-
nated birds could indicate that the CD4+ T cells are un-
able to maintain such metabolic pressure, which triggers
the additional CD8+ T cells infiltration in the upper re-
spiratory tract of vaccinated turkeys.
Studies of other respiratory infections demonstrated
that CD8+ T memory cells confer immunity to reinfec-
tion by restricting the spread of the virus at the site of
its replication [22,23] but in turn, they may be directly
responsible for damage to the host’s anatomical struc-
tures (e.g. mucous membranes) [24]. The question that
arises in connection with our results is whether the pres-
ence of maternal antibodies interferes with the acquisi-
tion of T memory cells after vaccination against TRT.
Further research is needed to examine the role of CD4+
and/or CD8+ T memory cells in protection against
aMPV infections.
As demonstrated earlier, the TRT virus has immuno-
suppressive activity [25-28]. In our study a significant
decrease in CD4+ and/or CD8+ T ACC in tracheal mu-
cosa was noted in vaccinated birds 3–7 DPV in Experi-
ments II - IV. Although, we can not assume that the
above changes are indicative of T cell immunosuppres-
sion we may speculate that attenuated aMPV strains
could also deliver such effects. Further research is neces-
sary to establish whether aMPV vaccine strains possess
immunosuppressive activity and if this activity in vivo
could depend on specific antibody levels and birds’ age
on the day of vaccination.
The role of double positive CD4+CD8+ T cells in the
host’s immune response has not yet been fully eluci-
dated, but in some production lines of hens those cells
were found to represent a significant percentage of T
lymphocytes in secondary immune structures [29].
Double-positive T cells could also have regulatory func-
tions or could play the role of both T helper cells and
cytotoxic T cells [30]. As it turned out in our study, this
parameter varied significantly only in MDA- vaccinated
turkeys.
Although most of the cited authors concluded their
studies based on relative T cell count and not ACC,these values are highly proportional. Therefore it can be
concluded that differences exist in the development and
activation of CMI in the upper respiratory tract of tur-
keys vaccinated against TRT, and that those variations
are correlated mainly with the birds’ age and maternal
antibody level on the day of vaccination. The cited ex-
periments produced similar results despite the use of
different aMPV strains, which seems to suggest that dif-
ferences in TRT immunopathogenesis are not strain-
related [6,7,17].
In our study, MDA+0/V was the only group of vac-
cinated birds that did not produce anti-aMPV IgY
antibodies in response to vaccination. On day 3 PV,
anti-aMPV antibody level in the serum of MDA+0/V
birds was significantly lower in comparison with un-
vaccinated birds. Those findings are partly consistent
with results reported by Cook et al. [12] who did not ob-
serve an increase in serum levels of specific anti-aMPV
antibodies in most MDA+ chickens vaccinated against
TRT on the first day of life. In our experiment, a faster de-
crease in MDA levels in MDA+0/V birds after vaccination
could be attributed to immunophagocytosis.
MDA+14/V and both MDA- vaccinated groups of tur-
keys responded to vaccination by producing specific IgY
anti-aMPV antibodies that were detected in the serum
(but not in tracheal washings) at 100-fold dilution on 14
DPV. In MDA-14/V birds, the level of those antibodies
were elevated already on day 7 PV. Those results indi-
cate that the level and the time required to induce
humoral immunity after TRT vaccination are determined
by age and MDA level on the day of vaccination. The
above could impair early assessment of vaccine-induced
immunity against TRT based on the results of routine
serological monitoring which also has other disadvan-
tages [4,31-33].
The absolute count of IgM+ B cells is a general, non-
specific indicator of humoral immunity stimulation after
vaccination. In this study, the only group of birds in
which this parameter did not change or decreased sig-
nificantly was MDA+0/V. A significant decrease in IgM+
B ACC in HG was also reported in the MDA-14/V
group on day 14 PV, but in this case, it was probably
compensated by intensive IgM+ B cell infiltration in tra-
cheal mucosa.
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ity of upper respiratory tract. IgA+ B cells and specific
IgA participates in the local immune response against
TRT in the upper respiratory tract [15]. Absolute counts
of IgA+ B cells and the levels of specific IgA were not
determined in this study, but it could be hypothesized
that, similarly to IgM+ B cell infiltration and specific IgY
production, the production of specific IgA could also de-
pend on the MDA level and the age of birds on the day
of vaccination against TRT. Further research is needed
to determine the involvement of IgA+ B cells and the
role of IgA in protection against aMPV infections.
The observed differences in aMPV/A replication in
nasal choanae between the MDA+0/V and MDA-0/V
groups could be associated with high antibody levels in
MDA+ birds upon vaccination. High levels of the these
immunoglobulins probably facilitated and stimulated
(upon immunophagocytosis) viral clearance from the
upper respiratory tract, as suggested earlier by Cook
et al. [11,12].
In both groups vaccinated on 14 DOL, aMPV/A RNA
was practically undetectable in choanal swabs. Despite
the above, the upper respiratory tract immune system
was strongly stimulated in those groups after vaccin-
ation. Those results partially corroborate the findings of
Rubbenstroth and Rautenschlein [16] who reported very
high levels of vaccine-induced immunity against aMPV
infections despite the fact the aMPV/A RNA was not
regularly detected in nasal turbinates of turkeys vacci-
nated against TRT on 13 or 14 DOL. Differences be-
tween birds vaccinated at different age suggest that the
replication of vaccine aMPV/A is limited during the
maturation of the immune and/or respiratory system,
but this does not influence the development of vaccine-
induced immunity.
This work has some limitations. Given the fact that
MDA+ and MDA- turkeys had different origin we were
unable to perform statistical analysis of assayed parame-
ters between them. However we could trace the diversity
of their development after vaccination in each experi-
ment in comparison to adequate not vaccinated control
group. To ensure the reproducibility of the results, in
each experiment, before the vaccination the birds were
confirmed to be free (with PCR technique) from other
common respiratory pathogens Mycoplasma spp., Ornitho-
bacterium rhinotracheale, Bordetella avium and Newcastle
Disease Virus (data not shown). Experiments I and III as
well as II and IV were performed simultaneously. Addition-
ally, birds for experiment I and II as well as III and IV were
obtained from the hatcheries at the same time.
Conclusion
Previous studies demonstrated that, under laboratory
conditions, the live attenuated vaccines are highlyefficient in protecting against TRT [7,9,17,21]. On the
other hand, despite vaccination, TRT outbreaks are fre-
quently observed in the field [7-9], which may stem not
only from aMPV high virulence but, additionally, from
differences in post-vaccination immunity development
in birds with diversified immunological status and from
the impact of other negative environmental and micro-
biological agents.
From the perspective of our study, at least a few
pathomechanisms of this adverse situation may be con-
cluded: (I) possible immunosuppressive activity of aMPV
vaccine strains causing disorders in T cells activity or T
cells activation, (II) possible disorders in antigen specifi-
city acquisition of B and/or T lymphocytes in MDA+
groups, (III) high infiltration of CD8+ T lymphocytes in
TC of MDA- groups, that (most likely) is not neutral to
the morphology of tracheal mucosa, as well as (IV) tem-
porary character of CD4+ T lymphocytes increase in the
upper respiratory tract of MDA+ birds.
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